Profound Medical Corp
NASDAQ:PROF

Watchlist Manager
Profound Medical Corp Logo
Profound Medical Corp
NASDAQ:PROF
Watchlist
Price: 6.38 USD -2.74%
Market Cap: $156.2m

Wall Street
Price Targets

PROF Price Targets Summary
Profound Medical Corp

Wall Street analysts forecast PROF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PROF is 11.6 USD with a low forecast of 11.48 USD and a high forecast of 11.94 USD.

Lowest
Price Target
11.48 USD
80% Upside
Average
Price Target
11.6 USD
82% Upside
Highest
Price Target
11.94 USD
87% Upside
Profound Medical Corp Competitors:
Price Targets
GWH
ESS Tech Inc
134% Upside

Revenue
Forecast

N/A
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

The compound annual growth rate of Profound Medical Corp's revenue for the next 3 years is 71%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PROF's stock price target?
Price Target
11.6 USD

According to Wall Street analysts, the average 1-year price target for PROF is 11.6 USD with a low forecast of 11.48 USD and a high forecast of 11.94 USD.

What is Profound Medical Corp's Revenue forecast?
Projected CAGR
71%

The compound annual growth rate of Profound Medical Corp's revenue for the next 3 years is 71%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett